Your browser doesn't support javascript.
loading
Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
Schijns, Virgil; Tartour, Eric; Michalek, Jaroslav; Stathopoulos, Apostolos; Dobrovolskiene, Neringa T; Strioga, Marius M.
Afiliação
  • Schijns V; Immune Intervention, Cell Biology & Immunology Group, Wageningen University, Wageningen, The Netherlands; Epitopoietic Research Corporation, Namur, Belgium.
  • Tartour E; INSERM U970, PARCC, Université Paris Descartes, Paris, France; Service d'Immunologie Biologique, Hopital Européen Georges Pompidou, Paris, France.
  • Michalek J; Advanced Cell Immunotherapy Unit, Department of Pharmacology, Medical Faculty, Masaryk University, Brno, Czech Republic; Cellthera Ltd, Brno, Czech Republic.
  • Stathopoulos A; Epitopoietic Research Corporation, Namur, Belgium; Department of Neurosurgery, Les Cliniques du Sud Luxembourg, Arlon, Belgium.
  • Dobrovolskiene NT; Department of Immunology, Center of Oncosurgery, Institute of Oncology, Vilnius University, Vilnius, Lithuania.
  • Strioga MM; Department of Immunology, Center of Oncosurgery, Institute of Oncology, Vilnius University, Vilnius, Lithuania. Electronic address: marius.strioga@vuoi.lt.
Cytotherapy ; 16(4): 427-39, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24280238

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Imunidade Inata / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Imunidade Inata / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article